| IV-065 Peter Velickovic Translational pharmacology and dose rationale for imatinib and doramapimod as a host-directed therapy for the treatment of pulmonary tuberculosis Thursday 15:00-16:30 |
| IV-065 Peter Velickovic Translational pharmacology and dose rationale for imatinib and doramapimod as a host-directed therapy for the treatment of pulmonary tuberculosis Thursday 15:00-16:30 |